ALESSANDRA OLIVA

Work experiences:
• Current position (02 May 2025- now): Associate Professor in Infectious Diseases, Sapienza University of Rome
• 01 August 2019-now: Infectious Diseases Physician, Azienda Ospedaliera-Universitaria Policlinico Umberto I, Rome;
• (02 May 2022-01 May 2025): Assistant Professor in Infectious Diseases, Sapienza University of Rome;
• (01 August 2018-01 May 2022): Researcher at Sapienza University of Rome, Department of Public Health and Infectious Diseaes;
• 13 April 2016-31 July 2018: Infectious Diseases Consultant at Neuromed Istituto Neurologico Mediterraneo, Pozzilli (IS)
• 01 August 2018-31 July 2019: Research contract of research and clinical activity at Neuromed Istituto Neurologico Mediterraneo, Pozzilli (IS);
• 09 May 2016-29 June 2018: Infectious Diseases Consultant, Policlinico Umberto I Sapienza University of Rome
• April 2016-31 July 2019: member of hospital infection committee (Comitato per le Infezioni Ospedaliere) at Neuromed Istituto Neurologico Mediterraneo, Pozzilli (IS)
• January 2015-may 2016: Post-doctoral fellowship at Sapienza University of Rome (Department of Public Health and Infectious Diseases);
• May 2014-July 2018: Infectious Diseases Consultant at Intensive Care Unit of Nuova Clinica Latina (Via Patrica 15, Rome);
• 26 April 2012-31 January 2013: Infectious Diseases Department-Septic Surgery CHUV (Centre Hospitalier Universitaire Vaudois), Lausanne (Switzerland)

Education:
• 03-11/03/2025: Visiting Professor at the Hospital Universitario Virgen Macarena, Unidad Clínica de Enfermedades Infecciosas y Microbiología, and Department of Medicine, Universidad de Sevilla (Prof. Jesús Rodríguez Baño)
• November 2011-November 2014: PhD in “Scienze Infettivologiche” University “Sapienza” of Rome (topic: multi-drug resistant bacteria)
• 27-28/03/2014: ESCMID Postgraduate Education Course “Bloodstream Infections: Management and Research” in Seville (ES)
• 16/11/2013: ESCMID Postgraduate Education Course “Antibiotic Awareness, Quality Prescriping & Infection Control in Clinical Practice” in Tubingen (GE)
• March-December 2012: Master “Sepsi in Chirurgia”
• June 2012: course “Resal Reseau des animaleries lemanique” (FELASA B category course) at Unil (Universite de Lausanne)
• 15/04-25/04/2012: Infectious Diseases Department-Septic Surgery CHUV (Centre Hospitalier Universitaire Vaudois), Lausanne (Switzerland), Observership program in collaboration with ESCMID (European Society of Clinical Microbiology and Infectious Diseases)
• July 2011: Specialization in Infectious and Tropical Diseases, Sapienza University of Rome
• 2007-2011: Residency in Infectious and Tropical Diseases, Sapienza University of Rome
• September 2006: Degree in Medicine and Surgery, Sapienza University of Rome
• 2005-2007: Fellowship at Policlinico Umberto I di Roma - Department of Infectious Diseases Sapienza University of Rome- Viale del Policlinico 155, Roma
• August 2005: Fellowship at Infectious Diseases Department, ClujNapoca (Romania), in collaboration with Sapienza University of Rome
• August 2004: Fellowship at Internal Medicine Department, Olomouc (Repubblica Ceca), in collaboration with Sapienza University of Rome
• February-October 2004: Fellowship at Gastroenterology at Policlinico Umberto I, Sapienza University of Rome
• September 2003: Internal Medicine Azienda Ospedaliera S. Camillo-Forlanini, Roma

Advanced courses

• SITA CAMPUS: Formazione avanzata in terapia antinfettiva, effettuato nelle seguenti date: 07-09/03/2018, 13-15/06/2018, 07-09/11/2018 in Milano.
• VI Residential Course “Statistica per economia, scienze sociali, epidemiologia clinica e sanità pubblica”, tenutosi a Firenze, 09-14/09/2018
• GCP Investigator Training Program Workshop, presso Policlinico Umberto I Sapienza Università di Roma, 18/02/2019
• GCP Investigator Training Program, 21/05/2025
• GCP Investigator Training Program, 23/02/2021
• May-October 2021 Corso di Alta Formazione “L’ecografia nelle urgenze e nel trauma: E-FAST-CRASH”, Sapienza Università di Roma

Academic and Tutoring Activity

• Genuary 2018-December 2020: Young Ambassador of the American Society of Microbiology for Italy.
• Lead Guest Editor of the Special Issue entitled “New insights into infections due to multi-drug resistant (MDR) Gram negative bacteria (GNB): the interplay between lab and clinic” in Biomed Research International.
• October 2018-now: teaching activity at the Medicine degree course “Infectious Diseases”
• March 2019-now: teaching activity at Phisiotherapy degree course (Infectious Diseases), Pozzilli (IS)
• 2013- now: teaching activity in the Medicine degree course “Patologia Integrata V” and “Medicina e Chirurgia I”
• 2016-2018: Teaching activities at Policlinico Umberto I, Sapienza University of Rome regarding “Antibiotic prophylaxis in surgery”
• Rapporteur in several Degree theses in Infectious Diseases
• Co-rapporteur in several graduation (Infectious Diseases, Biotechnology) and specialization (Infectious Diseases, Internal Medicine, Gerontology) theses
• Member of the Evaluation Committee “InfectionLab Under 40. Giovani Infettivologi a confronto. Final Contest.”. Milan, 04-05 October 2018.
• Member of the Evaluation Committee “InfectionLab Under 40. Giovani Infettivologi a confronto. Final Contest.”. Bologna, 02-03 October 2017.
• Member of the Evaluation Committee “InfectionLab Under 40. Giovani Infettivologi a confronto. Final Contest.”. Rome, 29-30 September 2016.
• 18/09/2021-now: Associate Editor Frontiers in Cellular and Infection Microbiology – Section Clinical Microbiology
• 2020: Reviewer of “Junior Research Groups in Infection Research” (recognized by BMBF, German Ministry of Education and Research)
• 2020: Topic Editor of the Research Topic entitled “Enterobacteriaceae Antimicrobial Agents and Resistance: Relationship with the Therapeutic Approach” in Frontiers in Cellular and Infection Microbiology – Section Clinical Microbiology
• 2018- 2021: tutoring activity of a PhD student for the Phd in Infectious Diseases “Dottorato in Malattie Infettive, Microbiologia e Sanità Pubblica (XXXIV ciclo), Sapienza Università di Roma

Research Grants and Awards:
• 2024-2026: Participation at the PRIN 2022 project (title “Lipophagoids as innovative therapeutic tools of precision medicine against multi-drug resistant bacteria”, numero progetto 20224T3X8K) - CUP B53D23003140006, funded by PNRR-Missione 4 “Istruzione e Ricerca” - Componente C2 Investimento 1.1 UE – NEXTGENERATION EU.
• 2022-2025: participation at the NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT, spoke 3 and spoke 4).
• 2019: Research grant from Sapienza University of Rome (“Progetto di Ateneo”) with the project “Role of microbial translocation, inflammation and intestinal damage in the development of nosocomial bloodstream infections following Clostridium difficile infection”
• 2014: Research grant from Sapienza University of Rome (“Avvio alla Ricerca”) with the project: “Study of synergic activity of different antimicrobial combinations against carbapenem-resistant Klebsiella pneumoniae isolated from patients with sepsis or systemic infections”
• 2013: Research grant from Sapienza University of Rome (“Avvio alla Ricerca”) with the project: “Implant-associated infections: role of sonication in the microbiological diagnosis and in vitro study of antimicrobial activity against biofilm-embedded microorganisms.”
• 2008: Award HERACLES 2008 with the work: “Sviluppo di Sarcoma di Kaposi come manifestazione di sindrome da immunoricostituzione (iris) dopo inizio precoce di terapia antiretrovirale” at SIMIT conference 2008.
• 2021: Selected for publication on the volume “PALADINI ITALIANI DELLA SALUTE” for the research entitled “DETERMINANTS OF PROLONGED VIRAL RNA SHEDDING IN PATIENTS WITH COVID-19”
• January 2018-December 2020: Young Ambassador for Italy for the American Society of Microbiology
• 23/10/2019: Award (2nd classificated) at the project “SHARE (Sharing Hospital Anti-Infective Real-life Experiences)” with the research entitled: “Follow up blood cultures in Gram-negative bacilli bacteremia: are they needed for critically ill patients?”

Achievement of the National Scientific Qualification (Abilitazione Scientifica Nazionale) of Associate Professor SSD (Settore Scientifico Disciplinare) 06/D4 MALATTIE CUTANEE, MALATTIE INFETTIVE E MALATTIE DELL'APPARATO DIGERENTE, valid from 14/01/2020 to 14/01/2029

Publications on peer-reviewed journals:

1. Cosimi L, Zerbato V, Grasselli Kmet N, Oliva A, Cogliati Dezza F, Geremia N, Cattaneo D, Nadrah K, Pirs M, Saletinger R, Nunnari A, Mearelli F, Di Girolamo FG, Avena G, Russo R, Fabiani C, Venturini S, Principe L, Nicolò GM, Di Bella S. Temocillin: A Narrative Review of Its Clinical Reappraisal. Antibiotics (Basel). 2025 Aug 26;14(9):859. doi: 10.3390/antibiotics14090859. PMID: 41009838; PMCID: PMC12466873.
2. Sambri V, Agnoletti V, Ambretti S, Bartoletti M, Bernaschi P, Bignami EG, Busani S, Campoli C, Carretto E, Catena F, Coloretti I, Cricca M, De Pascale G, De Rosa FG, Fontana C, Gherardi G, Giannella M, Girardis M, Mancini N, Oliva A, Podda M, Piazza O, Portunato F, Poletti V, Viceconte G, Rocchetti A, Santonastaso DP, Serapide F, Stefani S, Tascini C, Tebano G, Tosi M, Tumbarello M, Viaggi B, Viale P, Cristini F; Russo Multidisciplinary Collaborative Group. The Role of Rapid and Advanced Microbiological Methods in Critical Care: 2025 EMANUELE RUSSO Delphi Consensus. Clin Microbiol Infect. 2025 Aug 28:S1198-743X(25)00420-3. doi: 10.1016/j.cmi.2025.08.022. Epub ahead of print. PMID: 40885382.
3. Marino A, Maraolo AE, Mazzitelli M, Oliva A, Geremia N, De Vito A, Gullotta C, Scaglione V, Vania E, Lo Menzo S, Navalesi P, Volpicelli L, Fiori A, Prestifilippo P, Cattelan A, Mastroianni CM, Madeddu G, Cacopardo B, Nunnari G. Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections- results from a retrospective multicentre study. Infection. 2025 Jul 16. doi: 10.1007/s15010-025-02608-7. Epub ahead of print. PMID: 40668298.
4.
5. Bjerklund Johansen TE, Bahrs C, Bruyere F, Cai T, Joseph A, Köves B, Livermore DM, Oliva A, Soriano A, Wagenlehner F, Zahl PH, Etienne M; cUTI Consensus Group. Consensus position statement on advancing the classification of patients and tests of cure in studies of antibiotic treatment of complicated urinary tract infections. Lancet Infect Dis. 2025 May 13:S1473-3099(25)00142-2. doi: 10.1016/S1473-3099(25)00142-2. Epub ahead of print. PMID: 40378860.
6. Bodmann KF, Hagel S, Oliva A, Kluge S, Mularoni A, Galfo V, Falcone M, Pletz MW, Lindau S, Käding N, Kielstein JT, Zoller M, Tascini C, Kintrup S, Schädler D, Spies C, De Rosa FG, Radnoti S, Bandera A, Luzzati R, Allen S, Sarmati L, Cascio A, Kapravelos N, Subudhi CPK, Dimopoulos G, Vossen MG, Bal AM, Venditti M, Mastroianni CM, Borrmann T, Mayer C. Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study. Infect Dis Ther. 2025 Mar 19. doi: 10.1007/s40121-025-01125-2. Epub ahead of print. PMID: 40106180.
7. Pellicano C, Oliva A, Colalillo A, Luceri C, Gigante A, Mastroianni CM, Tornese D, Carnazzo V, Basile V, Rosato E, Basile U. Markers of Endotoxemia and Inflammation are Associated with Digital Ulcers in Systemic Sclerosis Patients. Immunol Invest. 2025 Mar 18:1-14. doi: 10.1080/08820139.2025.2478932. Epub ahead of print. PMID: 40099380.
8. Petrucci F, Pellicano C, Cogliati Dezza F, Valeri S, Covino S, Iannazzo F, Infante F, Gigante A, Sacco F, Viscido A, Iacovelli A, Rosato E, Palange P, Mastroianni CM, Oliva A. Effect of Secondary Infections on the Outcomes of Patients with Hematological Malignancies and SARS-CoV-2 Infection: Results from the HM-COV 3.0 Study. Viruses. 2025 Feb 16;17(2):274. doi: 10.3390/v17020274. PMID: 40007029; PMCID: PMC11861615.
9. Gentile I, Giuliano S, Corcione S, De Rosa FG, Falcone M, Giacobbe DR, Maraolo AE, Mastroianni CM, Oliva A, Pascale R, Tascini C, Tiseo G, Viale P, Bassetti M. Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: Expert opinion based on literature and real-life experiences. Expert Rev Anti Infect Ther. 2025 Jan 30. doi: 10.1080/14787210.2025.2461552. Epub ahead of print. PMID: 39882832.
10. Astolfi R, Oliva A, Raffo A, Sapienza F, Ragno A, Proia E, Mastroianni CM, Luceri C, Bozovic M, Mladenovic M, Papa R, Bottoni P, Mazzinelli E, Nocca G, Ragno R. Essential Oils as Antimicrobials against Acinetobacter baumannii: Experimental and Literature Data to Definite Predictive Quantitative Composition-Activity Relationship Models Using Machine Learning Algorithms. J Chem Inf Model. 2025 Jan 22. doi: 10.1021/acs.jcim.4c02389. Epub ahead of print. PMID: 39844439.
11. Geremia N, Di Bella S, Lovecchio A, Angelini J, D'Avolio A, Luzzati R, Mearelli F, Principe L, Oliva A. 'Real-life' approach to applying PK/PD principles in infectious diseases clinical practice without access to prompt TDM. Expert Rev Anti Infect Ther. 2025 Jan 2:1-16. doi: 10.1080/14787210.2024.2448727. Epub ahead of print. PMID: 39746901.
12. Oliva, A.; Petrucci, F.; Leanza, C.; Rivano Capparuccia, M.; Comi, M.; Mastroianni, C. Using Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients: A Real-Life, Single-Center Observational Study. Antibiotics 2025, 14, 75. https://doi.org/10.3390/antibiotics14010075
13. Oliva A, Volpicelli L, Gigante A. Assessment of actual renal function in critically ill patients with severe infections: Moving towards a personalized approach. Int J Antimicrob Agents. 2024 Dec 20;65(2):107417. doi: 10.1016/j.ijantimicag.2024.107417. Epub ahead of print. PMID: 39710144.
14. Oliva A, Curtolo A, Falletta A, Sacco F, Lancellotti F, Carnevalini M, Ceccarelli G, Roma G, Bufi M, Magni G, Raponi GM, Venditti M, Mastroianni CM. Efficacy of fosfomycin-containing regimens in treating severe infections caused by KPC-producing klebsiella pneumoniae and carbapenem-resistant acinetobacter baumannii in critically ill patients. Int J Antimicrob Agents. 2024 Dec;64(6):107365. doi: 10.1016/j.ijantimicag.2024.107365. Epub 2024 Oct 28. PMID: 39490539.
15. Oliva A, Volpicelli L, Gigante A, Di Nillo M, Trapani S, Viscido A, Sacco F, Mastroianni CM. Impact of renal-adjusted ceftazidime/avibactam in patients with KPC-producing Klebsiella pneumoniae bloodstream infection: a retrospective cohort study. JAC Antimicrob Resist. 2024 Dec 17;6(6):dlae201. doi: 10.1093/jacamr/dlae201. PMID: 39691790; PMCID: PMC11649808.
16. Pellicano C, Oliva A, Colalillo A, Gigante A, D'Aliesio E, Al Ismail D, Miele MC, Cianci R, Mastroianni CM, Rosato E. Serum markers of microbial translocation and intestinal damage in assessment of gastrointestinal tract involvement in systemic sclerosis. Clin Exp Med. 2024 Sep 19;24(1):225. doi: 10.1007/s10238-024-01466-1. PMID: 39294494; PMCID: PMC11410972.
17. Mascellino MT, Oliva A, Biswas S, Ceccarelli G. Editorial: New therapeutic strategies against carbapenem-resistant gram-negative bacteria. Front Microbiol. 2024 Nov 7;15:1513900. doi: 10.3389/fmicb.2024.1513900. PMID: 39575187; PMCID: PMC11578942.
18. Carnevale R, Nocella C, Marocco R, Zuccalà P, Carraro A, Picchio V, Oliva A, Cangemi R, Miele MC, De Angelis M, Cancelli F, Casciaro GE, Cristiano L, Pignatelli P, Frati G, Venditti M, Pugliese F, Mastroianni CM, Violi F, Ridola L, Del Borgo C, Palmerio S, Valenzi E, Carnevale R, Alvaro D, Lichtner M, Cardinale V. Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19. Antioxidants (Basel). 2024 Oct 17;13(10):1260. doi: 10.3390/antiox13101260. PMID: 39456513; PMCID: PMC11505442.
19. Ascione M, Dajci A, Cangiano R, Marzano A, Molinari A, Miceli F, Di Girolamo A, Leanza C, Oliva A, Di Marzo L, Mansour W. Open Surgical Conversion of Popliteal Endograft Infection: Case Reports and Literature Review. Biomedicines. 2024 Aug 15;12(8):1855. doi: 10.3390/biomedicines12081855. PMID: 39200319; PMCID: PMC11351597.
20. De Meo D, Martini P, Lo Torto F, Petrucci F, Ordonez Reyna J, Candela V, Iaiani G, Oliva A, Ribuffo D, Gumina S. Antibiotic-Loaded Hydrogel for the Treatment of Lower-Limb Fracture-Related Infections: A Single Center's Multidisciplinary Experience. Gels. 2024 Sep 29;10(10):628. doi: 10.3390/gels10100628. PMID: 39451281; PMCID: PMC11507492.
21. Volpicelli L, Oliva A. A role for ceftazidime/avibactam combination therapy: the question may still be on the table. Infection. 2024 Dec;52(6):2521-2522. doi: 10.1007/s15010-024-02331-9. Epub 2024 Jul 4. PMID: 38963608.
22. Leanza C, Mascellino MT, Volpicelli L, Covino S, Falletta A, Cancelli F, Franchi C, Carnevalini M, Mastroianni CM, Oliva A. Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections: a single-center preliminary experience. Front Microbiol. 2024 Jul 16;15:1432296. doi: 10.3389/fmicb.2024.1432296. PMID: 39081883; PMCID: PMC11286388.
23. Maraolo AE, Ceccarelli G, Venditti M, Oliva A. Short Course Antibiotic Therapy for Catheter-Related Septic Thrombosis: "Caveat Emptor!": Duration of Therapy Should Not Be Set a Priori. Pathogens. 2024 Jun 22;13(7):529. doi: 10.3390/pathogens13070529. PMID: 39057756; PMCID: PMC11280046.
24. Volpicelli L, Oliva A. A role for ceftazidime/avibactam combination therapy: the question may still be on the table. Infection. 2024 Jul 4. doi: 10.1007/s15010-024-02331-9. Epub ahead of print. PMID: 38963608.
25. Tumbarello M, Raffaelli F, Giannella M, De Pascale G, Cascio A, De Rosa FG, Cattelan AM, Oliva A, Saracino A, Bassetti M, Mussini C, Luzzati R, Capone A, Signorini L, Bartoletti M, Sambo M, Sarmati L, Antinori S, Mularoni A, Tascini C, Corona A, Pascale R, Rubino R, Corcione S, Mazzitelli M, Giuliano G, Lovecchio A, Bavaro DF, Meschiari M, Montagnani F, Fabbiani M, De Benedetto I, Antonelli M, Venditti M, Viale P. Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study. Open Forum Infect Dis. 2024 May 8;11(6):ofae273. doi: 10.1093/ofid/ofae273. PMID: 38854388; PMCID: PMC11161898.
26. Violi F, Bartimoccia S, Cangemi R, Nocella C, D'Amico A, Oliva A, Venditti M, Pugliese F, Mastroianni CM, Ridola L, Lichtner M, Cardinale V, Alvaro D, Cammisotto V, Castellani V, Pignatelli P, Carnevale R. Neutrophil Cathepsin G and Thrombosis in COVID-19. Circ Res. 2024 May 30. doi: 10.1161/CIRCRESAHA.124.324649. Epub ahead of print. PMID: 38813720.
27. Di Domenico EG, Oliva A, Guembe M. Biofilm-Related Infections in Healthcare: Moving towards New Horizons. Microorganisms. 2024 Apr 12;12(4):784. doi: 10.3390/microorganisms12040784. PMID: 38674728; PMCID: PMC11052091.
28. Silva NS, De Melo BST, Oliva A and de Arau´ jo PSR (2024). Sonication protocols and their contributions to the microbiological diagnosis of implant-associated infections: a review of the current scenario. Front. Cell. Infect. Microbiol. 14:1398461. doi: 10.3389/fcimb.2024.1398461
29. Oliva A, Liguori L, Covino S, Petrucci F, Cogliati-Dezza F, Curtolo A, Savelloni G, Comi M, Sacco F, Ceccarelli G, Viscido A, Alessandri F, Raponi G, Pugliese F, Mastroianni CM, Venditti M. Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study. Eur J Clin Microbiol Infect Dis. 2024 Apr 18. doi: 10.1007/s10096-024-04833-8. Epub ahead of print. PMID: 38634975.
30. Girardis M, Coloretti I, Antonelli M, Berlot G, Busani S, Cortegiani A, De Pascale G, De Rosa FG, De Rosa S, Donadello K, Donati A, Forfori F, Giannella M, Grasselli G, Montrucchio G, Oliva A, Pasero D, Piazza O, Romagnoli S, Tascini C, Viaggi B, Tumbarello M, Viale P. Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23. J Anesth Analg Crit Care. 2024 Apr 30;4(1):28. doi: 10.1186/s44158-024-00165-3. PMID: 38689337; PMCID: PMC11059820.
31. Russo A, Gullì SP, D'Avino A, Borrazzo C, Carannante N, Dezza FC, Covino S, Polistina G, Fiorentino G, Trecarichi EM, Mastroianni CM, Torti C, Oliva A. Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a multicenter clinical experience. Int J Antimicrob Agents. 2024 Apr 30:107190. doi: 10.1016/j.ijantimicag.2024.107190. Epub ahead of print. PMID: 38697579.
32. Di Domenico EG, Oliva A, Guembe M. Biofilm-Related Infections in Healthcare: Moving towards New Horizons. Microorganisms. 2024 Apr 12;12(4):784. doi: 10.3390/microorganisms12040784. PMID: 38674728; PMCID: PMC11052091.
33. Valeriani E, Falletta A, Pastori D, Porfidia A, Mastroianni CM, Di Bari S, Motta E, Pignatelli P, Oliva A. Midregional-proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta-analysis. Eur J Clin Invest. 2024 Apr 17:e14225. doi: 10.1111/eci.14225. Epub ahead of print. PMID: 38632681.
34. Iacovelli A, Oliva A, Mirabelli FM, Giannone S, Laguardia M, Morviducci M, Nicolardi ML, Repaci E, Sanzari MT, Leanza C, Raponi G, Mastroianni C, Palange P. Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit. BMC Infect Dis. 2024 Apr 11;24(1):392. doi: 10.1186/s12879-024-09283-3. PMID: 38605300.
35. Volpicelli L, Cairoli S, Ismail DA, Baisi F, Sacco F, Goffredo BM, Venditti M, Oliva A. Simultaneous post-neurosurgical ventriculitis and bacteremia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem/vaborbactam and high dose of fosfomycin. J Glob Antimicrob Resist. 2024 Mar 20:S2213-7165(24)00054-7. doi: 10.1016/j.jgar.2024.03.003. Epub ahead of print. PMID: 38519025.
36. Mascellino MT, Biswas S, Oliva A. Editorial: Enterobacteriaceae antimicrobial agents and resistance: relationship with the therapeutic approach, volume II. Front Cell Infect Microbiol. 2024 Jan 18;14:1356413. doi: 10.3389/fcimb.2024.1356413. PMID: 38304194; PMCID: PMC10830809.
37. Rando E, Salvati F, Sangiorgi F, Catania F, Leone E, Oliva A, Di Gennaro F, Fiori B, Cancelli F, Figliomeni S, Bobbio F, Sacco F, Bavaro DF, Diella L, Belati A, Saracino A, Mastroianni CM, Fantoni M, Murri R. Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study. J Antimicrob Chemother. 2024 Jan 3:dkad404. doi: 10.1093/jac/dkad404. Epub ahead of print. PMID: 38169441.
38. Oliva A, Cogliati Dezza F, Cancelli F, Curtolo A, Falletta A, Volpicelli L, Venditti M. New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended. J Clin Med. 2023 Dec 14;12(24):7693. doi: 10.3390/jcm12247693. PMID: 38137762; PMCID: PMC10743892.
39. Volpicelli L, Oliva A, Venditti M. Did the updated Duke criteria missed Erysipelothrix rhusiopathiae from the list of typical microorganisms causing infective endocarditis? Infez Med. 2023 Dec 1;31(4):425-428. doi: 10.53854/liim-3104-1. PMID: 38075421; PMCID: PMC10705859.
40. Arcari G, Cecilia F, Oliva A, Polani R, Raponi G, Sacco F, De Francesco A, Pugliese F, Carattoli A. Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy. Emerg Infect Dis. 2023 Nov;29(11):2266-2274. doi: 10.3201/eid2911.230921. PMID: 37877547; PMCID: PMC10617348.
41. Oliva A, De Rosa FG, Mikulska M, Pea F, Sanguinetti M, Tascini C, Venditti M. Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin. Expert Rev Anti Infect Ther. 2023 Aug 17:1-19. doi: 10.1080/14787210.2023.2240956. Epub ahead of print. PMID: 37494128.
42. Giannella M, Verardi S, Karas A, Abdel Hadi H, Dupont H, Soriano A, Santerre Henriksen A, Cooper A, Falcone M; ARES Study Group. Carbapenem-Resistant Acinetobacter spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic. Open Forum Infect Dis. 2023 Jul 4;10(7):ofad329. doi: 10.1093/ofid/ofad329. PMID: 37496600; PMCID: PMC10368198.
43. Cogliati Dezza F, Covino S, Petrucci F, Sacco F, Viscido A, Gavaruzzi F, Ceccarelli G, Raponi G, Borrazzo C, Alessandri F, Mastroianni CM, Venditti M, Oliva A. Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections and related mortality in critically ill patients with CRAB colonization. JAC Antimicrob Resist. 2023 Aug 10;5(4):dlad096. doi: 10.1093/jacamr/dlad096. PMID: 37577156; PMCID: PMC10412853.
44. Oliva A, Al Ismail D, Arcari G, Miele MC, Casali E, Sacco F, Volpicelli L, De Angelis M, Mascellino MT, Cancelli F, Raponi G, Carattoli A, Venditti M. Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations. J Glob Antimicrob Resist. 2023 Jun;33:321-327. doi: 10.1016/j.jgar.2023.03.012. Epub 2023 Apr 21. PMID: 37086891.
45. Oliva A, et al. Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Carbapenemase–Producing Klebsiella pneumoniae Infections: A Retrospective, Observational, 2-Center Clinical Study. Alessandra Oliva and others, Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Carbapenemase–Producing Klebsiella pneumoniae Infections: A Retrospective, Observational, 2-Center Clinical Study, Open Forum Infectious Diseases, Volume 10, Issue 7, July 2023, ofad327, https://doi.org/10.1093/ofid/ofad327
46. Cavallo I, Oliva A, Pages R, Sivori F, Truglio M, Fabrizio G, Pasqua M, Pimpinelli F, Di Domenico EG. Acinetobacter baumannii in the critically ill: complex infections get complicated. Front Microbiol. 2023 Jun 22;14:1196774. doi: 10.3389/fmicb.2023.1196774. PMID: 37425994; PMCID: PMC10325864.
47. Oliva A, Carbonara S, Cianci V, Crapis M, Di Domenico EG, Falcone M, Galardo G, Durante-Mangoni E, Venditti M. Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin. Expert Rev Anti Infect Ther. 2023 May 31:1-19. doi: 10.1080/14787210.2023.2214727. Epub ahead of print. PMID: 37227028.
48. Medioli F, Casali E, Viscido A, Pistolesi V, Venditti M, Oliva A. First case of persistent Stenotrophomonas maltophilia bacteremia due to septic thrombosis successfully treated with a cefiderocol-containing regimen. J Glob Antimicrob Resist. 2023 Jun 10:S2213-7165(23)00087-5. doi: 10.1016/j.jgar.2023.05.013. Epub ahead of print. PMID: 37307950.
49. Ciacci P, Paraninfi A, Orlando F, Rella S, Maggio E, Oliva A, Cangemi R, Carnevale R, Bartimoccia S, Cammisotto V, D'Amico A, Magna A, Nocella C, Mastroianni CM, Pignatelli P, Violi F, Loffredo L. Endothelial dysfunction, oxidative stress and low-grade endotoxemia in COVID-19 patients hospitalised in medical wards. Microvasc Res. 2023 Jun 1;149:104557. doi: 10.1016/j.mvr.2023.104557. Epub ahead of print. PMID: 37268038; PMCID: PMC10232918.
50. Gatto MC, Oliva A, Palazzolo C, Picariello C, Garascia A, Nicastri E, Girardi E, Antinori A. Efficacy and Safety of Anticoagulant Therapy in COVID-19-Related Pulmonary Embolism with Different Extension. Biomedicines. 2023 Apr 26;11(5):1282. doi: 10.3390/biomedicines11051282. PMID: 37238955; PMCID: PMC10215523.
51. Capitani V, Arcari G, Oliva A, Sacco F, Menichincheri G, Fenske L, Polani R, Raponi G, Antonelli G, Carattoli A. Genome-Based Retrospective Analysis of a Providencia stuartii Outbreak in Rome, Italy: Broad Spectrum IncC Plasmids Spread the NDM Carbapenemase within the Hospital. Antibiotics (Basel). 2023 May 22;12(5):943. doi: 10.3390/antibiotics12050943. PMID: 37237846; PMCID: PMC10215782.
52. Oliva A, Pallecchi L, Rossolini GM, Travaglino F, Zanatta P. Rationale and evidence for the adjunctive use of N-acetylcysteine in multidrug-resistant infections. Eur Rev Med Pharmacol Sci. 2023 May;27(9):4316-4325. doi: 10.26355/eurrev_202305_32342. PMID: 37203858.
53. Oliva A, Al Ismail D, Arcari G, Miele MC, Casali E, Sacco F, Volpicelli L, De Angelis M, Mascellino MT, Cancelli F, Raponi G, Carattoli A, Venditti M. Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: analysis of cases and evaluation of in-vitro activity of fosfomycin-containing combinations. J Glob Antimicrob Resist. 2023 Apr 20:S2213-7165(23)00058-9. doi: 10.1016/j.jgar.2023.03.012. Epub ahead of print. PMID: 37086891.
54. Rando E, Oliva A, Cancelli F, D'Agostino C, Savelloni G, Ciardi MR, Ajassa C, Siccardi G, Galardo G, Mastroianni CM. Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study. Infez Med. 2023 Mar 1;31(1):49-54. doi: 10.53854/liim-3101-7. PMID: 36908386; PMCID: PMC9994829.
55. Oliva A, Cogliati Dezza F, Petrucci F, Romani FE, Morviducci M, Mirabelli FM, Cancelli F, Valeriani E, Marcelli G, Pugliese F, Turriziani O, Ricci P, Venditti M, Palange P, Mastroianni CM. Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study. Clin Exp Med. 2023 Mar 3. doi: 10.1007/s10238-023-01027-y. Epub ahead of print. PMID: 36867292.
56. Volpicelli L, Venditti M, Oliva A. Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin. Expert Rev Anti Infect Ther. 2023 Feb 27:1-13. doi: 10.1080/14787210.2023.2182769. Epub ahead of print. PMID: 36803139.
57. Carnevale R, Cammisotto V, Bartimoccia S, Nocella C, Castellani V, Bufano M, Loffredo L, Sciarretta S, Frati G, Coluccia A, Silvestri R, Ceccarelli G, Oliva A, Venditti M, Pugliese F, Maria Mastroianni C, Turriziani O, Leopizzi M, D'Amati G, Pignatelli P, Violi F. Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection. Circ Res. 2023 Jan 13. doi: 10.1161/CIRCRESAHA.122.321541. Epub ahead of print. PMID: 36636919.
58. Loffredo L, Pignatelli P, Pirro M, Ceccarelli G, Oliva A, Maggio E, Cancelli F, D'Ardes D, Amitrano M, Zicari AM, Cinicola BL, Taliani G, Cangemi R, Lichtner M, Falcone M, Orlando F, Pugliese F, Venditti M, Mastroianni CM, Violi F; COVID-Group. Association between PaO2/FiO2 ratio and thrombotic events in COVID-19 patients. Intern Emerg Med. 2023 Jan 18:1–7. doi: 10.1007/s11739-023-03196-w. Epub ahead of print. PMID: 36650311; PMCID: PMC9845099.
59. Iacovelli A, Oliva A, Siccardi G, Tramontano A, Pellegrino D, Mastroianni CM, Venditti M, Palange P. Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University Hospital in Rome. BMC Pulm Med. 2023 Jan 20;23(1):30. doi: 10.1186/s12890-023-02315-9. PMID: 36670381.
60. Oliva A, Volpicelli L, Di Bari S, Curtolo A, Borrazzo C, Cogliati Dezza F, Cona A, Agrenzano S, Mularoni A, Trancassini M, Mengoni F, Stefani S, Raponi G, Venditti M. Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae: results from a multicentre retrospective study. JAC Antimicrob Resist. 2022 Dec 7;4(6):dlac121. doi: 10.1093/jacamr/dlac121. PMID: 36506890; PMCID: PMC9728520.
61. Corica B, Tartaglia F, Oliva A, Raparelli V, Cangemi R, Basili S, Lip GYH, Proietti M, Romiti GF. Prevalence of new-onset atrial fibrillation in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis. Intern Emerg Med. 2022 Nov 4:1–9. doi: 10.1007/s11739-022-03135-1. Epub ahead of print. PMID: 36333574; PMCID: PMC9638315.
62. Cogliati Dezza F, Oliva A, Mauro V, Romani FE, Aronica R, Savelloni G, Casali E, Valeri S, Cancelli F, Mastroianni CM. Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study. Infez Med. 2022 Jun 1;30(2):211-222. doi: 10.53854/liim-3002-6. PMID: 35693052; PMCID: PMC9177180.
63. Oliva A, Curtolo A, Volpicelli L, Cancelli F, Borrazzo C, Cogliati Dezza F, Marcelli G, Gavaruzzi F, Di Bari S, Ricci P, Turriziani O, Mastroianni CM, Venditti M. Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study. Infection. 2022 Oct;50(5):1383. doi: 10.1007/s15010-022-01892-x.
64. Cogliati Dezza F, Arcari G, Alessi F, Valeri S, Curtolo A, Sacco F, Ceccarelli G, Raponi G, Alessandri F, Mastroianni CM, Venditti M, Oliva A. Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared. Antibiotics (Basel). 2022 Jul 9;11(7):926. doi: 10.3390/antibiotics11070926. PMID: 35884179; PMCID: PMC9312122.
65. Di Domenico EG, Oliva A, Guembe M. The Current Knowledge on the Pathogenesis of Tissue and Medical Device-Related Biofilm Infections. Microorganisms. 2022 Jun 21;10(7):1259. doi: 10.3390/microorganisms10071259. PMID: 35888978; PMCID: PMC9322301.
66. Sacco F, Raponi G, Oliva A, Bibbolino G, Mauro V, Di Lella FM, Volpicelli L, Antonelli G, Venditti M, Carattoli A, Arcari A. An outbreak sustained by ST15 Klebsiella pneumoniae carrying 16S rRNA methyltransferases and blaNDM: evaluation of the global dissemination of these resistance determinants. Int J Antimicrob Agents. 2022 Aug;60(2):106615. doi: 10.1016/j.ijantimicag.2022.106615. Epub 2022 Jun 9. PMID: 35691602.
67. Pellicano C, Campagna R, Oliva A, Leodori G, Miglionico M, Colalillo A, Mezzaroma I, Mastroianni CM, Turriziani O, Rosato E. Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis. Clin Rheumatol. 2022 May 26:1–9. doi: 10.1007/s10067-022-06219-7. Epub ahead of print. PMID: 35614287; PMCID: PMC9132599.
68. Savelloni G, Gatto MC, Cancelli F, Barbetti A, Cogliati Dezza F, Franchi C, Carnevalini M, Galardo G, Bucci T, Alessandroni M, Pugliese F, Mastroianni CM, Oliva A. Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19. J Clin Med. 2022 Apr 30;11(9):2537. doi: 10.3390/jcm11092537. PMID: 35566664; PMCID: PMC9100038.
69. Oliva A, Cancelli F, Brogi A, Curtolo A, Savelloni G, Siccardi G, Marcelli G, Mazzuti L, Ricci P, Turriziani O, Antonelli G, Venditti M, Mastroianni CM. Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature. New Microbiol. 2022 Jan;45(1):62-72. Epub 2021 Dec 11. PMID: 35403848. IF: 2.479
70. Violi F, Pignatelli P, Vestri A, Spagnoli A, Cipollone F, Ceccarelli G, Oliva A, Amitrano M, Pirro M, Taliani G, Cangemi R, Lichtner M, Pugliese F, Falcone M, Venditti M, Mastroianni CM, Loffredo L. THE ADA (AGE-D-DIMER-ALBUMIN) SCORE TO PREDICT THROMBOSIS IN SARS-CoV-2. Thromb Haemost. 2022 Mar 4. doi: 10.1055/a-1788-7592. Epub ahead of print. PMID: 35253143. IF:5.249
71. Nicolardi ML, Oliva A, Masci GM, Ascoli V, Noccioli N, Mantovani S, Palange P. Lung on fire: a very severe case of fire-eater's lung. Thorax. 2022 Feb 14:thoraxjnl-2021-218470. doi: 10.1136/thoraxjnl-2021-218470. Epub ahead of print. PMID: 35165145. IF: 9.139
72. De Angelis M, Mascellino MT, Miele MC, Al Ismail D, Colone M, Stringaro A, Vullo V, Venditti M, Mastroianni CM, Oliva A. High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii. Antibiotics (Basel). 2022 Feb 10;11(2):225. doi: 10.3390/antibiotics11020225. PMID: 35203827; PMCID: PMC8868344. IF: 4.639
73. Tumbarello M, Raffaelli F, Cascio A, Falcone M, Signorini L, Mussini C, De Rosa FG, Losito AR, De Pascale G, Pascale R, Giacobbe DR, Oliva A, Farese A, Morelli P, Tiseo G, Meschiari M, Del Giacomo P, Montagnani F, Fabbiani M, Vargas J, Spanu T, Bassetti M, Venditti M, Viale P. Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study. JAC Antimicrob Resist. 2022 Mar 7;4(1):dlac022. doi: 10.1093/jacamr/dlac022. PMID: 35265842; PMCID: PMC8900192.
74. Volpicelli L, Venditti M, Ceccarelli G, Oliva A. Place in Therapy of the Newly Available Armamentarium for Multi-Drug-Resistant Gram-Negative Pathogens: Proposal of a Prescription Algorithm. Antibiotics (Basel). 2021 Nov 30;10(12):1475. doi: 10.3390/antibiotics10121475. PMID: 34943687; PMCID: PMC8698671. IF: IF: 4.639
75. Arcari G, Oliva A, Sacco F, Di Lella FM, Raponi G, Tomolillo D, Curtolo A, Venditti M, Carattoli A. Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report. Eur J Clin Microbiol Infect Dis. 2022 Jan 6:1–6. doi: 10.1007/s10096-021-04388-y. Epub ahead of print. PMID: 34988712; PMCID: PMC8731190. 3.267
76. Violi F, Pignatelli P, Oliva A, Cammisotto V. Reply to Chen and Vitetta. Clin Transl Gastroenterol. 2022 Jan 13. doi: 10.14309/ctg.0000000000000448. Epub ahead of print. PMID: 35029168. IF: 4.488
77. Tomao P, La Russa R, Oliva A, De Angelis M, Mansi A, Paba E, Marcelloni AM, Chiominto A, Padovano M, Maiese A, Scopetti M, Frati P, Fineschi V. Mapping Biological Risks Related to Necropsy Activities: Old Concerns and Novel Issues for the Safety of Health Professionals. Int J Environ Res Public Health. 2021 Nov 13;18(22):11947. doi: 10.3390/ijerph182211947. PMID: 34831702; PMCID: PMC8618163. IF:3.390
78. Oliva A, Miele MC, Al Ismail D, Di Timoteo F, De Angelis M, Rosa L, Cutone A, Venditti M, Mascellino MT, Valenti P, Mastroianni CM. Challenges in the Microbiological Diagnosis of Implant-Associated Infections: A Summary of the Current Knowledge. Front Microbiol. 2021 Oct 29;12:750460. doi: 10.3389/fmicb.2021.750460. PMID: 34777301; PMCID: PMC8586543. IF: 5.640
79. Cangemi R, Calvieri C, Falcone M, Cipollone F, Ceccarelli G, Pignatelli P, D'Ardes D, Pirro M, Alessandri F, Lichtner M, D'Ettorre G, Oliva A, Aronica R, Rocco M, Venditti M, Romiti GF, Tiseo G, Taliani G, Menichetti F, Pugliese F, Mastroianni CM, Violi F. Comparison of thrombotic events and mortality in patients with community-acquired pneumonia and COVID-19: a multicentre observational study. Thromb Haemost. 2021 Nov 10. doi: 10.1055/a-1692-9939. Epub ahead of print. PMID: 34758488. IF:5.249
80. Loffredo L, Fallarino A, Paraninfi A, Pacella F, Pacella E, Oliva A, Violi F. Different rates of conjunctivitis in COVID-19 eastern and western hospitalized patients: a meta-analysis. Intern Emerg Med. 2021 Nov 9. doi: 10.1007/s11739-021-02880-z. Epub ahead of print. PMID: 34750658. IF: 3.397
81. Oliva A, Stefani S, Venditti M, Di Domenico EG. Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin. Front Microbiol. 2021 Oct 22;12:749685. doi: 10.3389/fmicb.2021.749685. PMID: 34745053; PMCID: PMC8569946. IF: 5.640
82. Mascellino MT, Biswas S, Oliva A. Editorial: Enterobacteriaceae Antimicrobial Agents and Resistance: Relationship With the Therapeutic Approach. Front Cell Infect Microbiol. 2021 Sep 14;11:728371. doi: 10.3389/fcimb.2021.728371. PMID: 34595135; PMCID: PMC8476830.
83. Russo G, Solimini A, Zuccalà P, Zingaropoli MA, Carraro A, Pasculli P, Perri V, Marocco R, Kertusha B, Del Borgo C, Del Giudice E, Fondaco L, Tieghi T, D'Agostino C, Oliva A, Vullo V, Ciardi MR, Mastroianni CM, Lichtner M. Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study. PLoS One. 2021 Sep 10;16(9):e0257376. doi: 10.1371/journal.pone.0257376. PMID: 34506608; PMCID: PMC8432821.
84. Oliva A, Rando E, Al Ismail D, De Angelis M, Cancelli F, Miele MC, Aronica R, Mauro V, Di Timoteo F, Loffredo L, Mastroianni CM. Role of Serum E-Selectin as a Biomarker of Infection Severity in Coronavirus Disease 2019. J Clin Med. 2021 Sep 6;10(17):4018. doi: 10.3390/jcm10174018. PMID: 34501466; PMCID: PMC8432564.
85. Alessandra Oliva, CristianBorrazzo, Maria Teresa Mascellino, Ambrogio Curtolo, Dania Al Ismail, Francesca Cancelli, Gioacchino Galardo, Tommaso Bucci, Giancarlo Ceccarelli, Gabriella d’Ettorre, Francesco Pugliese, Claudio M.Mastroianni, Mario Venditti. CURB-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with SARS-CoV-2 pneumonia. Le Infezioni in Medicina n. 3, 408-415, 2021
86. Oliva A, Miele MC, Di Timoteo F, De Angelis M, Mauro V, Aronica R, Al Ismail D, Ceccarelli G, Pinacchio C, d'Ettorre G, Mascellino MT, Mastroianni CM. Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19. Front Immunol. 2021 Jul 14;12:708149. doi: 10.3389/fimmu.2021.708149. PMID: 34335624; PMCID: PMC8316921.
87. Mascellino MT, Di Timoteo F, De Angelis M, Oliva A. Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety. Infect Drug Resist. 2021 Aug 31;14:3459-3476. doi: 10.2147/IDR.S315727. PMID: 34511939; PMCID: PMC8418359.
88. Loffredo L, Oliva A, Paraninfi A, Ceccarelli G, Orlando F, Ciacci P, Pacella F, Pacella E, Bari SD, Filippi V, Cruciata A, Mastroianni CM, Violi F. An observed association between conjunctivitis and severity of COVID-19. J Infect. 2021 Jun 9:S0163-4453(21)00286-3. doi: 10.1016/j.jinf.2021.06.006. Epub ahead of print. PMID: 34118275.
89. Violi F, Ceccarelli G, Cangemi R, Cipollone F, D'Ardes D, Oliva A, Pirro M, Rocco M, Alessandri F, D'Ettorre G, Lichtner M, Pignatelli P, Ferro D, Ruberto F, Lip GYH, Pugliese F, Mastroianni CM; Intensive Care, Infectious Diseases COVID-19 Study Group of Sapienza University. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. Intern Emerg Med. 2021 Aug;16(5):1231-1237. doi: 10.1007/s11739-020-02621-8. Epub 2021 Jul 4. PMID: 34218413; PMCID: PMC8255055.
90. Oliva A, Curtolo A, Volpicelli L, Cogliati Dezza F, De Angelis M, Cairoli S, Dell'Utri D, Goffredo BM, Raponi G, Venditti M. Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing K. pneumoniae Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside. Antibiotics (Basel). 2021 Jun 27;10(7):781. doi: 10.3390/antibiotics10070781. PMID: 34199072.
91. Russo A, Gavaruzzi F, Ceccarelli G, Borrazzo C, Oliva A, Alessandri F, Magnanimi E, Pugliese F, Venditti M. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 2021 Jun 27:1-10. doi: 10.1007/s15010-021-01643-4. Online ahead of print. PMID: 34176088
92. Aprile F, Bruno G, Palma R, Mascellino MT, Panetta C, Scalese G, Oliva A, Severi C, Pontone S. Microbiota Alterations in Precancerous Colon Lesions: A Systematic Review. Cancers (Basel). 2021 Jun 19;13(12):3061. doi: 10.3390/cancers13123061. PMID: 34205378.
93. Violi F, Ceccarelli G, Cangemi R, Cipollone F, D'Ardes D, Oliva A, Pirro M, Rocco M, Alessandri F, D'Ettorre G, Lichtner M, Pignatelli P, Ferro D, Ruberto F, Lip GYH, Pugliese F, Mastroianni CM; Intensive Care, Infectious Diseases COVID-19 Study Group of Sapienza University. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. Intern Emerg Med. 2021 Jul 4:1-7. doi: 10.1007/s11739-020-02621-8. Online ahead of print. PMID: 34218413
94. Maselli R, Oliva A, Badalamenti M, Galtieri PA, Belletrutti PJ, Spadaccini M, Nicoletti R, Finati E, Vetrano S, Fosso F, Correale C, Pellegatta G, Hassan C, Repici A. Single-dose versus short-course prophylactic antibiotics for peroral endoscopic myotomy: a randomized controlled trial. Gastrointest Endosc. 2021 Jun 10;S0016-5107(21)01418-8. doi: 10.1016/j.gie.2021.05.045. Online ahead of print.
95. Oliva A, Cammisotto V, Cangemi R, Ferro D, Miele MC, De Angelis M, Cancelli F, Pignatelli P, Venditti M, Pugliese F, Mastroianni CM, Violi F. Low-Grade Endotoxemia and Thrombosis in COVID-19. Clin Transl Gastroenterol. 2021 Jun 4;12(6):e00348. doi: 10.14309/ctg.0000000000000348.
96. Oliva A, Ceccarelli G, Borrazzo C, Ridolfi M, D 'Ettorre G, Alessandri F, Ruberto F, Pugliese F, Raponi GM, Russo A, Falletta A, Mastroianni CM, Venditti M. Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission. Infection. 2021 May 26:1-11. doi: 10.1007/s15010-021-01624-7.
97. Oliva A, Savelloni G, Cancelli F, Valeri S, Mauro V, Aronica R, Romani F, Mastroianni CM. Real-life experience on the use of ceftobiprole for the treatment of nosocomial pneumonia: a case series. J Glob Antimicrob Resist. 2021 May 21;S2213-7165(21)00116-8. doi: 10.1016/j.jgar.2021.04.016
98. Oliva A, Franchi C, Gatto MC, Galardo G, Pugliese F, Mastroianni CM. Prevalence and clinical significance of relative bradycardia at hospital admission in patients with Coronavirus Disease 2019 (COVID-19). Clin Microbiol Infect. 2021 Apr 23;S1198-743X(21)00196-8. doi: 10.1016/j.cmi.2021.04.013. Online ahead of print.
99. Bibbolino G, Di Lella FM, Oliva A, Lichtner M, Del Borgo C, Raponi GM, Trancassini M, Mengoni F, Arcari G, Antonelli G, Carattoli A. Molecular Epidemiology of Escherichia coli producing NDM-5 in two Italian Hospitals in the 2017-2019 study period. Diagnostic Microbiology & Infectious Disease. 2021 Apr 20;100(4):115399. 10.1016/j.diagmicrobio.2021.115399
100. Oliva A, Bianchi A, Russo A, Ceccarelli G, Cancelli F, Aloj F, Alunni Fegatelli D, Mastroianni CM, Venditti M. Effect of N-Acetylcysteine Administration on 30-Day Mortality in Critically Ill Patients with Septic Shock Caused by Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii: A Retrospective Case-Control Study. Antibiotics (Basel). 2021 Mar 8;10(3):271. doi: 10.3390/antibiotics10030271.
101. Granata G, Petrosillo N, Adamoli L, Bartoletti M, Bartoloni A, Basile G, Bassetti M, Bonfanti P, Borromeo R, Ceccarelli G, De Luca AM, Di Bella S, Fossati S, Franceschini E, Gentile I, Giacobbe DR, Giacometti E, Ingrassia F, Lagi F, Lobreglio G, Lombardi A, Lupo LI, Luzzati R, Maraolo AE, Mikulska M, Mondelli MU, Mularoni A, Mussini C, Oliva A, Pandolfo A, Rogati C, Trapani FF, Venditti M, Viale P, Caraffa E, Cataldo MA, On Behalf Of The ReCloDi Recurrence Of Clostridioides Difficile Infection Study Group. Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections. J Clin Med. 2021 Mar 8;10(5):1127. doi: 10.3390/jcm10051127.
102. Ceccarelli G, Alessandri F, Oliva A, Borrazzo C, Dell'Isola S, Ialungo AM, Rastrelli E, Pelli M, Raponi G, Turriziani O, Ruberto F, Rocco M, Pugliese F, Russo A, d'Ettorre G, Venditti M. The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study). J Med Virol. 2021 Mar 6. doi: 10.1002/jmv.26925.
103. Maria Grazia Porpora, Lucia Merlino, Luisa Masciullo, Rossella D'Alisa, Gabriella Brandolino, Cecilia Galli, Casimiro De Luca, Francesco Pecorini, Giovanni Battista Fonsi, Andrea Mingoli, Cristiana Franchi, Alessandra Oliva, Lucia Manganaro, Claudio Maria Mastroianni, Maria Grazia Piccioni. Does Lung Ultrasound Have a Role in the Clinical Management of Pregnant Women with SARS COV2 Infection? Int J Environ Res Public Health. 2021 Mar 9;18(5):2762. doi: 10.3390/ijerph18052762.
104. Simona Gabrielli, Valentina Mangano, Federica Furzi, Alessandra Oliva, Serena Vita, Roberto Poscia, Paolo Fazii, Josephine Di Paolo, Raffaella Marocco, Claudio Maria Mastroianni, Fabrizio Bruschi, Simonetta Mattiucci. Molecular diagnosis of new cases of human dirofilariosis (Dirofilaria repens) in Italy. Pathogens. 2021 Feb 23;10(2):251. doi: 10.3390/pathogens10020251.
105. Mario Tumbarello, Francesca Raffaelli, Maddalena Giannella, Elisabetta Mantengoli, Alessandra Mularoni, Mario Venditti, Francesco Giuseppe De Rosa , Loredana Sarmati, Matteo Bassetti, Gaetano Brindicci, Marianna Rossi, Roberto Luzzati, Paolo Antonio Grossi, Alberto Corona, Alessandro Capone, Marco Falcone, Cristina Mussini, Enrico Maria Trecarichi, Antonio Cascio, Elena Guffanti, Alessandro Russo, Gennaro De Pascale, Carlo Tascini, Ivan Gentile, Angela Raffaella Losito, Linda Bussini, Giampaolo Conti, Giancarlo Ceccarelli, Silvia Corcione, Mirko Compagno, Daniele Roberto Giacobbe, Annalisa Saracino, Massimo Fantoni, Spinello Antinori, Maddalena Peghin, Paolo Bonfanti, Alessandra Oliva, Andrea De Gasperi, Giusy Tiseo, Cristina Rovelli, Marianna Meschiari, Nour Shbaklo, Teresa Spanu, Roberto Cauda, Pierluigi Viale. Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study. Clin Infect Dis. 2021 Feb 22;ciab176. doi: 10.1093/cid/ciab176. Online ahead of print
106. F Cogliati Dezza*, A Oliva*, F Cancelli, G Savelloni, S Valeri, V Mauro, M Calabretto, G Russo, M Venditti, O Turriziani, CM Mastroianni. Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection. Diagnostic Microbiology & Infectious Disease. 2021. https://doi.org/10.1016/j.diagmicrobio.2021.115347
107. Loffredo L, Campana A, Olivini N, Cotugno N, Palma P, Oliva A, Salvatori G, Zicari AM, Violi F. Hypoalbuminemia and Clinical Adverse Events in Children with COVID-19. J Med Virol. 2021 Feb 8. doi: 10.1002/jmv.26856. Online ahead of print
108. Francesco Cogliati Dezza, Ambrogio Curtolo, Lorenzo Volpicelli, Giancarlo Ceccarelli, Alessandra Oliva, Mario Venditti. Are Follow-Up Blood Cultures Useful in the Antimicrobial Management of Gram Negative Bacteremia? A Reappraisal of Their Role Based on Current Knowledge. Accepted on Antibiotics. doi: 10.3390/antibiotics9120895
109. Oliva A, Ceccarelli G, De Angelis M, Sacco F, Miele MC, Mastroianni CM, Venditti M. Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively- and pan-resistant Acinetobacter baumannii. J Glob Antimicrob Resist. 2020 Oct 13;23:292-296. doi: 10.1016/j.jgar.2020.09.019.
110. Curtolo A, Oliva A, Volpicelli L, Ceccarelli G, D'Ettorre G, Borrazzo C, Mastroianni CM, Venditti M. Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization. Infez Med. 2020 Dec 1;28(4):534-538
111. Lai S, Mazzaferro S, Mitterhofer AP, Tinti F, Giovannetti A, Casella C, Perrotta AM, Mastroluca D, Galani A, Marra A, Mazzarella A, Oliva A, Mastroianni CM, Palange P. Effects of non-invasive ventilation on renal and endothelial function in patients with respiratory failure. Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):11374-11380. doi: 10.26355/eurrev_202011_23629.
112. Ceccarelli G., Alessandri F., Oliva A., et al. Superinfections in patients treated with Teicoplanin as anti-SARSCoV2 agent. Eur J Clin Invest. 2020 Sep 30:e13418. doi: 10.1111/eci.13418.
113. Volpicelli L, Oliva A, Venditti M. The role of combination therapy in critically ill patients with methicillin susceptible Staphylococcus aureus blood stream infections: does the question remain? Clin Infect Dis. 2020 Aug 26:ciaa1259. doi: 10.1093/cid/ciaa1259.
114. Mascellino MT, Oliva A, Miele MC, De Angelis M, Bruno G, Severi C. Secondary Antibiotic Resistance, Correlation between Genotypic and Phenotypic Methods and Treatment in Helicobacter pylori Infected Patients: A Retrospective Study. Antibiotics (Basel). 2020 Aug 28;9(9):E549. doi: 10.3390/antibiotics9090549.
115. Oliva A, Siccardi G, Migliarini A, Cancelli F, Carnevalini M, D’Andria M, Attilia I, Danese VC, Cecchetti V, Romiti R, Ceccarelli G, Mastroianni CM, Palange P, Venditti M. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection. 2020 Jul 28:1-7. doi: 10.1007/s15010-020-01483-8.
116. Violi F, Oliva A, Cangemi R, Ceccarelli G, Pignatelli P, Carnevale R, Cammisotto V, Lichtner M, Alessandri F, De Angelis M, Miele MC, D’Ettorre G, Ruberto F, Venditti M, Pugliese F, Mastroianni CM. Nox2 activation in Covid-19. Redox Biol. 2020 Jul 25;36:101655. doi: 10.1016/j.redox.2020.101655.
117. Di Paolo M, Iacovelli A, Olmati F, Menichini I, Oliva A, Carnevalini M, Graziani E, Mastroianni CM, Palange P. False-negative RT-PCR in SARS-CoV-2 disease: experience from an Italian COVID-19 unit. ERJ Open Res. 2020 Jul 13;6(2):00324-2020. doi: 10.1183/23120541.00324-2020.
118. Violi F, Cangemi R, Romiti GF, Ceccarelli G, Oliva A, Alessandri F, Pirro M, Pignatelli P, Lichtner M, Carraro A, Cipollone F, d'ardes D, Pugliese F, Mastroianni C. IS ALBUMIN PREDICTOR OF MORTALITY IN COVID-19? Antioxid Redox Signal. 2020 Jun 11. doi: 10.1089/ars.2020.8142.
119. Violi F, Ceccarelli G, Cangemi R, Alessandri F, d'Ettorre G, Oliva A, Pastori D, Loffredo L, Pignatelli P, Ruberto F, Venditti M, Pugliese F, Mastroianni CM. Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19. Circ Res. 2020 Jun 8. doi: 10.1161/CIRCRESAHA.120.317173.
120. Ceccarelli G, Alessandri F, d'Ettorre G, Borrazzo C, Spagnolello O, Oliva A, Ruberto F, Mastroianni CM, Pugliese F, Venditti M. IS TEICOPLANIN A COMPLEMENTARY TREATMENT OPTION FOR COVID-19? THE QUESTION REMAINS. Int J Antimicrob Agents. 2020 May 23:106029. doi: 10.1016/j.ijantimicag.2020.106029.
121. Loffredo L, Pacella F, Pacella E, Tiscione G, Oliva A, Violi F. Conjunctivitis and COVID-19: a meta-analysis. J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25938.
122. Vena A, Giacobbe DR, Mussini C, Cattelan A, Bassetti M; Ceftabuse Study Group (Oliva A). Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa. Clin Infect Dis. 2020 Oct 23;71(7):1799-1801. doi: 10.1093/cid/ciaa003.
123. Federica Rinaldi, Alessandra Oliva, Manuela Sabatino, Anna Imbriano, Patrizia N. Hanieh, Stefania Garzoli, Claudio M. Mastroianni, Massimiliano De Angelis, Maria Claudia Miele, Marcela Arnaut, Federica Di Timoteo, Carlotta Marianecci, Rino Ragno,Maria Carafa. Antimicrobial Essential Oil Formulation: Chitosan Coated Nanoemulsions for Nose to Brain Delivery. Pharmaceutics 2020, 12(7), 678; https://doi.org/10.3390/pharmaceutics12070678.
124. Bassetti M, Vena A, Giacobbe DR, Falcone M, Tiseo G, Giannella M, Pascale R, Meschiari M, Digaetano M, Oliva A, Rovelli C, Carannante N, Losito AR, Carbonara S, Mariani MF, Mastroianni A, Angarano G, Tumbarello M, Tascini C, Grossi P, Mastroianni CM, Mussini C, Viale P, Menichetti F, Viscoli C, Russo A; CEFTABUSE Study Group. Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study). Open Forum Infect Dis. 2020 Apr 21;7(5):ofaa139. doi: 10.1093/ofid/ofaa139. eCollection 2020 May.
125. Spaziante M, Oliva A, Ceccarelli G, Venditti M. What are the treatment options for resistant Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria? Expert Opin Pharmacother. 2020 Jun 17:1-7. doi: 10.1080/14656566.2020.1779221.
126. Oliva A, Miele MC, De Angelis M, Costantini S, Mascellino MT, Mastroianni CM, Vullo V, d'Ettorre G. Antibacterial Effectiveness of Fecal Water and in Vitro Activity of a Multi-Strain Probiotic Formulation against Multi-Drug Resistant Microorganisms. Microorganisms. 2020 Feb 27;8(3). pii: E332. doi: 10.3390/microorganisms8030332
127. Spaziante M, Oliva A, Ceccarelli G, Alessandri F, Pugliese F, Venditti M. Follow up blood cultures in Gram-negative bacilli bacteremia: are they needed for critically ill patients? Minerva Anestesiol. 2020 Feb 25. doi: 10.23736/S0375-9393.20.14040-9.
128. Oliva A, Aversano L, De Angelis M, Mascellino MT, Miele MC, Morelli S, Battaglia R, Iera J, Bruno G, Corazziari ES, Ciardi MR, Venditti M, Mastroianni CM, Vullo V. Persistent Systemic Microbial Translocation, Inflammation, and Intestinal Damage During Clostridioides difficile Infection. Open Forum Infect Dis. 2019 Dec 3;7(1):ofz507. doi: 10.1093/ofid/ofz507.
129. Venosi S, Ceccarelli G, de Angelis M, Laghi L, Bianchi L, Martinelli O, Maruca D, Cavallari EN, Toscanella F, Vassalini P, Trinchieri V, Oliva A, d'Ettorre G. Infected chronic ischemic wound topically treated with a multi-strain probiotic formulation: a novel tailored treatment strategy. J Transl Med. 2019 Nov 9;17(1):364. doi: 10.1186/s12967-019-2111-0.
130. Bruno G, Gagliardi A, Oliva A, Trancassini M, Macone A, Cicerone C, D'Abramo A, Iebba V, Auria S, Bonfiglio G, Zingaropoli MA, D'Ettorre G, Badiali D, Vullo V, Corazziari ES, Schippa S. Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium difficile infection patients. New Microbiol. 2019 Oct;42(4):221-224. Epub 2019 Oct 14
131. Antonio Vena, Daniele Roberto Giacobbe, Nadia Castaldo, Annamaria Cattelan, Cristina Mussini, Roberto Luzzati, Francesco Giuseppe De Rosa, Filippo Del Puente, Claudio Maria Mastroianni, Antonio Cascio, Sergio Carbonara, Alessandro Capone, Silvia Boni, Chiara Sepulcri, Marianna Meschiari, Francesca Raumer, Alessandra Oliva, Silvia Corcione and Matteo Bassetti for the CEFTABUSE study group. Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales. Antibiotics. Antibiotics (Basel). 2020 Feb 9;9(2). pii: E71. doi: 10.3390/antibiotics9020071.
132. De Angelis M, Scagnolari C, Oliva A, Cavallari EN, Celani L, Santinelli L, Innocenti GP, Borrazzo C, Ceccarelli G, Vullo V, d'Ettorre G. Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects. Microorganisms. 2019 Jun 3;7(6). pii: E162. doi: 10.3390/microorganisms7060162.
133. Giacobbe DR, Saffioti C, Losito AR, Rinaldi M, Aurilio C, Bolla C, Boni S, Borgia G, Carannante N, Cassola G, Ceccarelli G, Corcione S, Gasperina DD, De Rosa FG, Dentone C, Di Bella S, Di Lauria N, Feasi M, Fiore M, Fossati S, Franceschini E, Gori A, Granata G, Grignolo S, Grossi PA, Guadagnino G, Lagi F, Maraolo AE, Marinò V, Mazzitelli M, Mularoni A, Oliva A, Pace MC, Parisini A, Patti F, Petrosillo N, Pota V, Raffaelli F, Rossi M, Santoro A, Tascini C, Torti C, Trecarichi EM, Venditti M, Viale P, Signori A, Bassetti M, Del Bono V, Giannella M, Mikulska M, Tumbarello M, Viscoli C; SITA GIOVANI, (young investigators group of the Società Italiana Terapia Antinfettiva), the COLI-CROSS study group. Use of colistin in adult patients: a cross-sectional study. J Glob Antimicrob Resist. 2019 Jun 14. pii: S2213-7165(19)30153-5. doi: 10.1016/j.jgar.2019.06.009.
134. Pavone P, Oliva A, Raponi G, Pugliese F, Martelli S, Celli P, Sacco F, Vullo V, Mastroianni CM, Russo G. Disseminated fungal infection due to Saprochaete clavata in a kidney transplant recipient. J Mycol Med. 2019 Jun 13. pii: S1156-5233(19)30046-0. doi: 10.1016/j.mycmed.2019.06.002.
135. Luigi Rosa, Maria Stefania Lepanto, Antimo Cutone, Francesca Berlutti, Massimiliano De Angelis, Vincenzo Vullo, Claudio Maria Mastroianni, Piera Valenti, Alessandra Oliva. BioTimer assay as complementary method to vortex-sonication-vortex technique for the microbiological diagnosis of implant associated infections. Scientific Reports (2019) 9:7534.
136. Alessandra Oliva, Stefania Garzoli, Massimiliano De Angelis, Carolina Marzuillo, Vincenzo Vullo, Claudio M. Mastroianni, Rino Ragno. In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant Acinetobacter Baumannii. Molecules. Molecules. 2019 Mar 3;24(5).
137. Oliva A., Gabrielli S., Pernazza A. , Pagini A., Daralioti T. , Mantovani S. , Mattiucci S. , D’Amati G., Mastroianni C.M. Dirofilaria repens infection mimicking lung melanoma metastasis. Open Forum Infectious Diseases. Open Forum Infect Dis. 2019 Feb 9;6(3):ofz049. doi: 10.1093/ofid/ofz049.
138. Carillo C, Pecoraro Y, Anile M, Poggi C, Oliva A, Amore D, Bruschini P, Naldi G, Mantovani S, Francioni F, Pugliese F, De Giacomo T, Venuta F, Diso D. Colistin-based Treatment of Multidrug-resistant Gram-negative Bacterial Pulmonary Infections After Lung Transplantation. Transplant Proc. 2019 Jan - Feb;51(1):202-205.
139. Matteo Bassetti, Nadia Castaldo , Annamaria Cattelan , Cristina Mussini , Elda Righi , Carlo Tascini , Francesco Menichetti , Claudio Maria Mastroianni , Mario Tumbarello , Paolo Grossi , Stefania Artioli , Novella Carrannante , Ludovica Cipriani , Davide Coletto , Alessandro Russo , Margherita Digaetano , Raffaella Losito , Maddalena Peghin , Alessandro Capone , Stefano Nicole , Antonio Vena , for the CEFTABUSE study group. Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience. International Journal of Antimicrobial Agents (2018), doi: https://doi.org/10.1016/j.ijantimicag.2018.11.001.
140. Oliva A, Giacobbe DR, Di Luca M, Miller NS. New Insights into Infections due to Multidrug Resistant Gram Negative Bacteria: The Interplay between Lab and Clinic. Biomed Res Int. 2018 Dec 25;2018:8905874. doi: 10.1155/2018/8905874. eCollection 2018.
141. Oliva A, Garzoli S, Sabatino M, Tadić V, Costantini S, Ragno R, Božović M. Chemical composition and antimicrobial activity of essential oil of Helichrysum italicum (Roth) G. Don fil. (Asteraceae) from Montenegro. Nat Prod Res. 2019 Jan 3:1-4. doi: 10.1080/14786419.2018.1538218.
142. Cancelli F, Oliva A, De Angelis M, Mascellino MT, Mastroianni CM, Vullo V. Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae: A Single-Center, Observational Study. Biomed Res Int. 2018 Nov 18;2018:2785696.
143. Oliva A, Costantini S, De Angelis M, Garzoli S, Božović M, Mascellino MT, Vullo V, Ragno R. High Potency of Melaleuca alternifolia Essential Oil against Multi-Drug Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus aureus. Molecules. 2018 Oct 9;23(10).
144. Oliva A, Mascellino MT, Nguyen BL, De Angelis M, Cipolla A, Di Berardino A, Ciccaglioni A, Mastroianni CM, Vullo V. Detection of Biofilm-associated Implant Pathogens in Cardiac Device Infections: High Sensitivity of Sonication Fluid Culture Even in the Presence of Antimicrobials. J Glob Infect Dis. 2018 Apr-Jun;10(2):74-79.
145. Mascellino MT, Oliva A, De Angelis M, Pontone S, Porowska B. Helicobacter pylori infection: antibiotic resistance and eradication rate in patients with gastritis showing previous treatment failures. New Microbiol. 2018 Oct;41(4):306-309.
146. d’Ettorre G, Oliva A, De Angelis M, Vullo V. Response to: Ectopic Colonization of oral bacteria in the intestine drives Th1 cell induction and inflammation. Science. November 2017.
147. Maria Antonella Zingaropoli, Marco Iannetta, Simona Pontecorvo, Elena Anzivino, Carla Prezioso, Donatella Maria Rodio, Manuela Morreale, Alessandra D'Abramo, Alessandra Oliva, Miriam Lichtner, Antonio Cortese, Marco Frontoni, Valeria Pietropaolo, Ada Francia, Claudio M. Mastroianni, Vincenzo Vullo and Rosa Maria Ciard. JC virus-DNA detection is associated with CD8 effector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus. BioMed Research International. Biomed Res Int. 2018 Feb 27;2018:5297980. doi: 10.1155/2018/5297980.
148. Tadić V, Oliva A, Božović M, Cipolla A, De Angelis M, Vullo V, Garzoli S, Ragno R. Chemical and Antimicrobial Analyses of Sideritis romana L. subsp. purpurea (Tal. ex Benth.) Heywood, an Endemic of the Western Balkan. Molecules. 2017 Aug 23;22(9).
149. Oliva A, Cipolla A, Vullo V, Venditti M, Mastroianni CM, Falcone M. Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia. New Microbiol. 2017 Jul;40(3):205-207.
150. Oliva A, Scorzolini L, Cipolla A, Mascellino MT, Cancelli F, Castaldi D, D'Abramo A, D'Agostino C, Russo G, Ciardi MR, Mastroianni CM, Vullo V. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value. J Antimicrob Chemother. 2017 Jul 1;72(7):1981-1984.
151. Mascellino MT, Porowska B, De Angelis M, Oliva A. Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection. Drug Des Devel Ther. 2017 Jul 28;11:2209-2220.
152. Composition of the Essential Oil of Coristospermum cuneifolium and Antimicrobial Activity Evaluation. Venditti A, Frezza C, Salutari G, di Cecco M, Ciaschetti G, Oliva A, De Angelis M, Vullo V, Sabatino M, Garzoli S, Pepi F, Ragno R, Serafini M, Bianco A. Planta Med Int Open 2017; 4: e74–e81.
153. Carillo C, Pecoraro Y, Anile M, Mantovani S, Oliva A, D'Abramo A, Amore D, Pagini A, De Giacomo T, Pugliese F, Rendina EA, Venuta F, Diso D. Evaluation of Renal Function in Patients Undergoing Lung Transplantation. Transplant Proc. 2017 May;49(4):699-701.
154. Mascellino MT, De Angelis M, Oliva A. Multi-Drug Resistant Gram-Negative Bacteria: Antibiotic-Resistance and New Treatment Strategies. Diagn Pathol Open 2017, 2:1. DOI: 10.4172/2476-2024.1000e106
155. Pugliese ME, Falcone M, Oliva A, Faccenna F, D’Aluisio D, Morelli S. Aeromonas hydrophila endocarditis with ruptured mycotic aneurysm of right renal artery. Infectious Disease Reports 2016; volume 8:6515.
156. Oliva A, Scorzolini L, Castaldi D, Gizzi F, De Angelis M, Storto M, D'Abramo A, Aloj F, Mascellino MT, Mastroianni CM, Vullo V. Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp). J Infect. 2016 Oct 25. pii: S0163-4453(16)30253-5. doi: 10.1016/j.jinf.2016.10.002.
157. Iannetta M,
 Zingaropoli MA, D’Abramo A, Oliva A,
 Mastroianni CM, Vullo
V, Ciardi MR. HIV-associated progressive multifocal leukoencephalopathy: current perspectives. Neurobehavioral HIV Medicine 2016:7 1–10.
158. Anzivino E, Zingaropoli MA, Iannetta M, Pietropaolo VA, Oliva A, Iori F, Ciardi A, Rodio DM, Antonini F, Fedele CG, D'Abramo A, Mastroianni CM, Vullo V, Ciardi MR. Archetype and Rearranged Non-coding Control Regions in Urothelial Bladder Carcinoma of Immunocompetent Individuals. Cancer Genomics Proteomics. 2016 11-12;13(6):499-509.
159. Iannetta M, Zingaropoli MA, Bellizzi A, Morreale M, Pontecorvo S, D'Abramo A, Oliva A, Anzivino E, Lo Menzo S, D'Agostino C, Mastroianni CM, Millefiorini E, Pietropaolo V, Francia A, Vullo V, Ciardi MR. Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation. PLoS One. 2016 Aug 3;11(8):e0160277. doi: 10.1371/journal.pone.0160277.
160. A. Oliva, A. Cipolla, F. Gizzi, A. D’Abramo, M. Favaro, Massimiliano De Angelis, G. Ferretti, G. Russo, M. Iannetta, C.M. Mastroianni, M.T. Mascellino, V. Vullo. Severe bloodstream infection due to KPC-producer E. coli in a renal transplant recipient treated with the double-carbapenem regimen and analysis of in-vitro synergy testing: a case report. Medicine. Medicine (Baltimore). 2016 Feb;95(7):e2243.
161. Maiolo EM, Oliva A, Furustrand Tafin U, Perrotet N, Borens O, Trampuz A. Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection. J Infect. 2016 Mar;72(3):386-92.
162. D'Abramo A, Zingaropoli MA, Oliva A, D'Agostino C, Al Moghazi S, De Luca G, Iannetta M, d'Ettorre G, Ciardi MR, Mastroianni CM, Vullo V. Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. PLoS One. 2016 Feb 25;11(2):e0149601.
163. Ceccarelli G, Oliva A, d'Ettorre G, D'Abramo A, Caresta E, Barbara CS, Mascellino MT, Papoff P, Moretti C, Vullo V, Visca P, Venditti M. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit. BMC Infect Dis. 2015 Sep 30;15:393.
164. Oliva Alessandra, Gizzi Francesca, Mascellino Maria Teresa, Cipolla Alessia, D’Abramo Alessandra, D’Agostino Claudia, Trinchieri Vito, Russo Gianluca, Tierno Francesca, Iannetta Marco, Mastroianni Claudio Maria, Vullo Vincenzo. Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae. Clin Microbiol Infect. 2015 Sep 23.
165. Oliva A, Pavone P, D’Abramo A, Iannetta M, Mastroianni CM, Vullo V. Role of sonication in the microbiological diagnosis of implant-associated infections: beyond the orthopedic prosthesis. Advances in Microbiology, Infectious Diseases and Public Health Series. Adv Exp Med Biol. 2015 Nov 14.
166. Nguyen BL, Persi A, Gang ES, Fattorini F, Oliva A, Vitarelli A, Alessandri N, Siegel RJ, Ciccaglioni A, Gaudio C. Three-Dimensional Binding Sites Volume Assessment during Cardiac Pacing Lead Extraction. Clinical Trials and Regulatory Science in Cardiology. In press.
167. Mascellino MT, Oliva A, De Angelis M, Porowska B. Helicobacter pylori infection: susceptibilty to antimicrobials and eradication rate in pluritreated pangastritis patients Indian Journal of Applied Research. Volume 5, Issue 4. April 2015.
168. Oliva A, Mascellino MT, Cipolla A, D'Abramo A, De Rosa A, Savinelli S, Ciardi MR, Mastroianni CM, Vullo V. Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen. Int J Infect Dis. 2015 Jan 15;
169. D’Abramo A, Zingaropoli MA, Oliva A, D’Agostino C, Al Moghazi S, De Luca G, Iannetta M, Mastroianni CM, Vullo V. Immune activation, immunosenescence and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. Mediators of inflammation. 2014;2014:192594.
170. Alessandra Oliva, Alessandra D'Abramo, Claudia D'Agostino, Marco Iannetta, Maria T. Mascellino, Carmela Gallinelli, Claudio M. Mastroianni, Vincenzo Vullo. Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections. J Antimicrob Chemother. 2014 Feb 11.
171. Mihailescu R, Furustrand Tafin U, Corvec S, Oliva A, Betrisey B, Borens O, Trampuz A. High activity of fosfomycin and rifampin against methicillin-resistant Staphylococcus aureus (MRSA) biofilm in vitro and in experimental foreign-body infection model. Antimicrob. Agents Chemother. AAC.02420-12.
172. D’Abramo A., D’Agostino C., Oliva A., Iannetta M., d’Ettorre G., Vullo F., Mancone M., Ciardi RM.,, Mastroianni CM., Vullo V. Early Atherosclerosis in HIV infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin. ISRN AIDS. 2013. Dec 5.
173. Oliva A, Tafin UF, Maiolo EM, Jeddari S, Bétrisey B, Trampuz A. Activity of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis in an experimental foreign-body infection model. Antimicrob Agents Chemother. 2013 Oct 21.
174. Baldoni D, Furustrand Tafin U, Aeppli S, Angevaare E, Oliva A, Haschke M, Zimmerli W, Trampuz A. Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model. Int J Antimicrob Agents. 2013 Sep;42(3):220-5.
175. Iannetta M, Bellizzi A, Lo Menzo S, Anzivino E, D'Abramo A, Oliva A, D'Agostino C, d'Ettorre G, Pietropaolo V, Vullo V, Ciardi MR. HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity. J Neurovirol. 2013 Jun;19(3):274-9.
176. A. Oliva, M. Lichtner, M.T. Mascellino, M. Iannetta, A.M. Ialungo, S. Tadadjeu Mewamba, P. Pavone, F. Mengoni, C.M. Mastroianni, V. Vullo. Study of Methicillin-Resistant Staphylococcus aureus (MRSA) carriage in a population of HIV-negative migrants and HIV-infected patients attending an outpatient clinic in Rome. Ann Ig. 2013 Mar-Apr;25(2):99-107.
177. Alessandra Oliva, Bich Lien Nguyen, Maria T. Mascellino, Alessandra D’Abramo, Marco Iannetta, Antonio Ciccaglioni, Vincenzo Vullo, Claudio M. Mastroianni. Sonication of Explanted Cardiac Implants Improves Microbial Detection in Cardiac Device Infections. J. Clin. Microbiol. doi:10.1128/JCM.02230-12.
178. Russo G, Iannetta M, D'Abramo A, Mascellino MT, Pantosti A, Erario L, Tebano G, Oliva A, D'Agostino C, Trinchieri V, Vullo V. Lactococcus garvieae endocarditis in a patient with colonic diverticulosis: first case report in Italy and review of the literature. New Microbiol. 2012 Oct;35(4):495-501. Epub 2012 Oct 1.
179. Mascellino M., Boccia P, Oliva A (2011). Immunopathogenesis In Chlamydia Trachomatis infected women. ISRN OBSTET GYNECOL. Volume 2011, Article ID 436936, 9 pages. doi:10.5402/2011/436936.
180. Mascellino M., A. Oliva, R. Notarnicola, C. Gallinelli, F. Chiarini (2011). Prevalence of methicillin-resistant Staphylococci isolated from different biological samples at Policlinico Umberto I of Rome: correlation with vancomycin susceptibility. MICROBIOLOGIA MEDICA, vol. 26; p. 11-13, ISSN: 1120-0146
181. Mascellino M., Porowska B, Oliva A, Boccia P, Severi C (2010). Impact of Helicobacter pylori resistance in unsuccesfully pluritreated patients. MICROBIOLOGY RESEARCH, vol. 2:e2; p. 9-14, ISSN: 2036-7473, doi: 10.4081/mr.2010.e2
182. Oliva A, Belvisi V, Iannetta M, Andreoni C, Mascellino M., Lichtner M, Vullo V, Mastroianni CM (2010). Pacemaker lead endocarditis due to multi-drug resistant Corynebacterium striatum detected with sonication of the device. JOURNAL OF CLINICAL MICROBIOLOGY, ISSN: 0095-1137
183. Mascellino M, Margani M, Oliva A. (2009). Helicobacter pylori: determinant of virulence and markers. DISEASE MARKERS, vol. 27; p. 137-156, ISSN: 0278-0240
184. Russo GL, Lichtner M, Carnevalini M, Mascellino M., Mengoni F, Oliva A, Miccoli GA, Iannetta M, Trinchieri V, Massetti AP, Mastroianni CM, Vullo V (2009). Primary Retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tygecicline. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol. 14; p. 127-131, ISSN: 1201-9712
185. Mascellino M., Ciardi M.R, Oliva A, Cecinato F, Borgese L (2008). Chlamydia trachomatis detection in a population of asymptomatic and symptomatic women: correlation with the presence of serological markers for this infection. NEW MICROBIOLOGICA, 31; 249-256, ISSN: 1121-7138
186. Mancini G., Erario L., Gianfreda R., Oliva A., Massetti A.P., Mastroianni C.M., Vullo V. (2007). “Tuberculosos and Legionella pneumophila pneumonia in a patient receiving anti TNFalpha treatment” Clinical Microbiology And Infection. Oct;13(10):1036-7;
187. V. Di Bari, F. Di Campli, R. Rossi, M.C. Rizza, G. Mancini, A. Oliva, M. Lichtner, A.P. Massetti, C.M. Mastroianni, V. Vullo. (2006), “Un caso di encefalite da VZV a lenta risoluzione: ruolo del monitoraggio delle cellule dendritiche del sangue periferico” GIORNALE ITALIANO DI MALATTIE INFETTIVE; volume 12, pg 210.

Book chapters:
• Mastroianni C.M., Oliva A, Vullo V. Endocarditi e miocarditi infettive. Manuale di Malattie Infettive. Capitolo 14.
• “Medical Device Pre- and post- implant testing” (Epidemiologic and Infection Control Microbiology section, Section 13) in CLINICAL MICROBIOLOGY PROCEDURES HANDBOOK, Fourth Edition (CMPH4)
• “Pre-endoscopy screening of Helicobacter pylori infection: Implication and advantages” in Endoscopy of GI tract, March 2013.
Invited Speaker at international conferences
• POST-ECCMID Meeting organized by PharmaAdvance, 07/06/2022;
• Workshop on Prosthetic Joint Infection (Berlin) 18-19 March 2019 organized by Prof. A. Trampuz.
• Workshop on Prosthetic Joint Infection (Berlin) 5-6 March 2015 organized by Prof. A. Trampuz.
• Workshop on Prosthetic Joint Infection (Berlin) 1-2 June 2015 organized by Prof. A. Trampuz.
• Workshop on Prosthetic Joint Infection (Berlin) 22-23 March 2016 organized by Prof. A. Trampuz.
• Workshop on Prosthetic Joint Infection (Berlin) 5-6 June 2016 organized by Prof. A. Trampuz.
• Workshop on Prosthetic Joint Infection (Berlin) 10-11 October 2015 organized by Prof. A. Trampuz.
• Workshop on Prosthetic Joint Infection (Berlin) 24-25 November 2015 organized by Prof. A. Trampuz.
• MEETING OF ESCMID STUDY GROUP FOR BIOFILMS (ESGB) Biofilm - based Healthcare - associated Infections: From Microbiology to Clinics. IRCCS Fondazione Santa Lucia

Activity as reviewer in several journals

Member of:
• Italian Society of Infectious and Tropical Diseases (SIMIT)
• European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
• American Society of Microbiology (ASM)
• Società Italiana di Terapia Antibiotica (SITA)

Other:
• Partecipation at different research and clinical studies at Policlinico Umberto I, Sapienza University of Rome.
• Partecipation at the research project INAIL BRIC_06 (Infectious Diseases Section): “Valutazione e gestione del rischio biologico, fisico e chimico in sede di sopralluogo giudiziario, e nelle attività necroscopiche ed obitoriali”.
• Partecipation at the research project “Risk of Microbial Translocation in patients undergoing Per-Oral Endoscopic Myotomy (POEM) for Achalasia: Antibiotic Prophylaxis or Short-therapy?” Humanitas Research Hospital Milano
• Project “Infections Following NeuroSurgery (INS)”: Clinical and Microbiological Analyses of Infections Following NeuroSurgery: a Retrospective, Single-center Study (ClinicalTrials.gov ID: NCT03857295)
• Author of several abstracts presented at international conferences